We speak
fluent
pharma.
Ninety seconds on the thinking that starts before the brief.
Ninety seconds on the thinking that starts before the brief.
Efficacy first. Safety second. Heritage third.
Everyone speaks it beautifully.
fluency stops being the differentiator.
Being worth hearing becomes it.
are not the same thing.
The regulator approves the science. The market decides whether it matters.
Getting heard is the start.
Being remembered is the job.
Stated as territory, not sold as services.
The thinking is the product. These are the rooms it works in.
No account-management chain between your challenge and the person thinking about it. Fluent in the regulatory reality, so ideas arrive workable — not wishful.
PulseHealth is led by Daryl Stewart.
Nearly four decades across advertising, branding, strategic communications and the pharmaceutical industry — on both sides of the table. Developing the ideas, and approving them.
Which means we know what your internal review will say before it says it.
If that question stays with you — pulseintensive.com